cGMP Capability The Center for Biocatalysis and Bioprocessing operates a state-of-the-art cGMP production facility in Iowa capable of manufacturing protein products for Phase 1 clinical studies, presenting a strong value proposition for biotech startups and mid-size biopharma seeking compliant early-stage manufacturing.

End-to-End Solutions CBB offers comprehensive services from process development through large-scale production, enabling clients to streamline development timelines, reduce vendor coordination, and protect IP by consolidating fermentation, purification, and scale-up under one partner.

Academic Synergy Strong ties to the University of Iowa and NIH-funded biotechnology training programs provide access to academic collaborations, talent pipelines, and cutting-edge R&D, which can be leveraged for joint projects, sponsored research, and early access to innovative methods.

Small-to-Mid Market Focus With a team size of 11-50 and revenue in the low-to-mid millions, CBB is well-positioned to engage biotech startups and mid-market companies seeking flexible, hands-on collaboration, rapid iterations, and personalized customer service.

Diverse Capabilities A broad capability set including fermentation and protein purification, together with a broad technical toolbox (MATLAB, Docker, SOLIDWORKS, etc.), supports customized workflows, enabling targeted outreach to clients needing scalable microbial manufacturing and process development expertise.